CSPC Pharma says China clears clinical trial for RSV vaccine candidate SYS 6057PUBT·12 hours ago01093+0.35%
CSPC says FDA clears CRB-701 pivotal trial in second-line oropharyngeal cancerPUBT·2 days ago, 07:34 AMCRBP-0.88%01093+0.35%
CSPC PHARMA Marketing Application for Sirolimus for Injection AcceptedAASTOCKS News·Jul 27 at 09:07 PM01093+0.35%
CSPC PHARMA HA1406 Enteric-coated Tablets for Depression Treatment Meet Primary Endpoint in Phase III Clinical TrialAASTOCKS News·Jul 27 at 09:07 PM01093+0.35%
Morgan Stanley Remains a Buy on CSPC Pharmaceutical Group (CHJTF)Tip Ranks·2 days ago, 07:36 PM01093+0.35%
CSPC says China NMPA accepts sirolimus albumin-bound injection filing, grants priority reviewPUBT·Jul 27 at 07:58 AM01093+0.35%300765+5.61%
CSPC PHARMA Expects Interim Consolidated Profit of Approximately RMB5.9B-6.2BAASTOCKS News·Jul 27 at 04:44 AM01093+0.35%300765+5.61%
CSPC Innovation Pharma, CSPC Pharmaceutical Group unit, forecasts H1 net profit at 1.18 billion-1.36 billion yuanPUBT·Jul 27 at 04:34 AM01093+0.35%300765+5.61%
CSPC Pharma expects H1 profit attributable to owners at RMB 5.9 billion-RMB 6.2 billionPUBT·Jul 27 at 04:32 AM01093+0.35%AZN-0.99%
CSPC Sees Profit Surge on AstraZeneca Deal and Solid Drug SalesTip Ranks·Jul 27 at 04:37 AM01093+0.35%AZN-0.99%
Nomura Cuts CSPC PHARMA TP to HKD10.31, Expects Mild Growth in 2Q Drug SalesAASTOCKS News·Jul 26 at 10:47 PM01093+0.35%
Nomura Expects AKESO to Swing to Interim Profit of RMB46M, Maintains Buy RatingAASTOCKS News·Jul 26 at 11:59 PM09926+0.80%
Nomura Raises WUXI BIO TP to HKD51.38, Estimates 1H Profit to Drop 15%AASTOCKS News·Jul 27 at 02:22 AMWXXWY+1.86%02269+2.49%
WuXi Biologics Recognized by FTSE4Good for the Sixth Consecutive Year, Underscoring Value Creation Through Green CRDMOPR Newswire·2 days ago, 09:27 PMWXXWY+1.86%02269+2.49%
